Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-benzyl-3-pyrrolidinyl Methyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
2. Barnidipine
3. Cyress
4. Libradin
5. Mepirodipine
6. Mepirodipine Hydrobromide, (s,s)-isomer
7. Mepirodipine Hydrochloride, (r,r)-isomer
8. Mepirodipine Hydrochloride, (r,s)-isomer
9. Mepirodipine Hydrochloride, (s,r)-isomer
10. Mepirodipine Hydrochloride, (s,s)-isomer
11. Mepirodipine Malate, (s,s)-isomer
12. Mepirodipine Oxalate, (r,s)-isomer
13. Mepirodipine Oxalate, (s,s)-isomer
14. Mepirodipine, (r,r)-isomer
15. Mepirodipine, (r,s)-isomer
16. Mepirodipine, (s,r)-isomer
17. Ym 09730
18. Ym-09730
1. Barnidipine Hcl
2. 104757-53-1
3. Mepirodipine Hydrochloride
4. Barnidipine Hydrochloride [jan]
5. Barnidipine (hydrochloride)
6. 7lz6r3aem1
7. Chembl2093893
8. 104757-53-1 (hcl)
9. Barnidipine Hydrochloride (jan)
10. (s)-3-((s)-1-benzylpyrrolidin-3-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
11. 3-((s)-1-benzylpyrrolidin-3-yl) 5-methyl (s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Hydrochloride
12. Unii-7lz6r3aem1
13. Cyress
14. Hypoca
15. Ym730
16. Hypoca (tn)
17. Ym-09730-5
18. Barnidipinehydrochloride
19. Ly198561
20. Ym09730-5
21. Ncgc00181772-01
22. Ym 09730-5
23. Dsstox_cid_28580
24. Dsstox_rid_82851
25. Dsstox_gsid_48654
26. Schembl347963
27. Chembl2356712
28. Dtxsid8048654
29. Chebi:31253
30. Bcp12810
31. Tox21_113010
32. Bdbm50226128
33. Eu-730
34. Mfcd00915772
35. Ym-730
36. Barnidipine Hydrochloride [mi]
37. Barnidipine Hydrochloride [mart.]
38. (s-(r*,r*))-methyl 1-(phenylmethyl)-3-pyrrolidinyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
39. Barnidipine Hydrochloride [who-dd]
40. Hy-107322
41. Ly-198561
42. Cas-104757-53-1
43. Cs-0028139
44. D01104
45. 757b531
46. J-001245
47. Q27268545
48. (+)-(3's,4s)-1-benzyl-3-pyrrolidinyl Methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate Hydrochloride
49. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, Methyl 1-(phenylmethyl)-3-pyrrolidinyl Ester, Hydrochloride, (s-(r*,r*))-
50. 3,5-pyridinedicarboxylic Acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, Methyl 1-(phenylmethyl)-3-pyrrolidinyl Ester, Monohydrochloride, (s-(r*,r*))-
51. 5-o-[(3s)-1-benzylpyrrolidin-3-yl] 3-o-methyl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
| Molecular Weight | 528.0 g/mol |
|---|---|
| Molecular Formula | C27H30ClN3O6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 8 |
| Exact Mass | 527.1823134 g/mol |
| Monoisotopic Mass | 527.1823134 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 917 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
ABOUT THIS PAGE
A Barnidipine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Barnidipine Hydrochloride, including repackagers and relabelers. The FDA regulates Barnidipine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Barnidipine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Barnidipine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Barnidipine Hydrochloride supplier is an individual or a company that provides Barnidipine Hydrochloride active pharmaceutical ingredient (API) or Barnidipine Hydrochloride finished formulations upon request. The Barnidipine Hydrochloride suppliers may include Barnidipine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Barnidipine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Barnidipine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Barnidipine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Barnidipine Hydrochloride GMP manufacturer or Barnidipine Hydrochloride GMP API supplier for your needs.
A Barnidipine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Barnidipine Hydrochloride's compliance with Barnidipine Hydrochloride specifications and serves as a tool for batch-level quality control.
Barnidipine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Barnidipine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Barnidipine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Barnidipine Hydrochloride EP), Barnidipine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Barnidipine Hydrochloride USP).
LOOKING FOR A SUPPLIER?
